Browsing by Author Pan, CQ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 5 of 5
TitleAuthor(s)Issue Date
 
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
Journal:PLoS One
Pan, CQChang, TTBae, SHBrunetto, MSeto, WKCoffin, CSTan, SKMo, SFlaherty, JFGaggar, ANguyen, MHCelen, MKThompson, AGane, EJBulterys, M
2021
 
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks
Journal:Alimentary Pharmacology and Therapeutics
Fung, SKPan, CQWong, GLSeto, WKAhn, SHChen, CYHann, HLJablkowski, MSKim, YJYurdaydin, CPeng, CYNguyen, TYatsuhashi, HFlaherty, JFYee, LJAbramov, FWang, HAbdurakhmanov, DLim, YSButi, M
31-Oct-2023
 
High Rates of Viral Suppression After Long-term Entecavir Treatment of Asian Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B
Journal:Clinical Gastroenterology and Hepatology
Pan, CQTong, MKowdley, KVHu, KChang, TLai, CYoon, SKLee, SSCohen, DTang, HTsai, N
2012
 
IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Proceeding/Conference:Hepatology
Lim, YChan, HLYSeto, WKWNing, QAgarwal, KJanssen, HLPan, CQChuang, WLIzumi, NFung, SKShalimar,Brunetto, MRFlaherty, JFMo, SCheng, CLin, LGaggar, ASubramanian, MMarcellin, PGane, EJHou, JButi, M
2019
 
Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
Proceeding/Conference:Hepatology
Chan, HLYLim, YSSeto, WKWAgarwal, KBrunetto, MRJanssen, HLACaruntu, FStepanova, TTsang, OYatsuhashi, HTak, WYChen, CYCelen, MSun, VFlaherty, JFLin, LCathcart, AGaggar, APan, CQShalimarButi, M
2018
Showing results 1 to 5 of 5